The stock of Sun Pharma Advanced Research Company has gained 8.8 per cent with above average volume on Thursday, breaching a key resistance at ₹149. It has been in limelight over the past four trading sessions. The recent rally gives traders with a short-term perspective an opportunity to buy the stock at current levels of ₹154.7.
The stock can extend the uptrend and reach the price targets of ₹161 and ₹164 in the ensuing trading sessions. Buy the stock with a stop-loss at ₹151.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.